Pharmaceutical

Opinion: Excited delirium: a deadly term finally laid to rest

Opinion: Excited delirium: a deadly term finally laid t...

Oct 28, 2023

An emergency room doctor celebrates the end of the fake medical condition “excit...

Emergency medicine is grappling with a surprising problem: The prospect of too many physicians

Emergency medicine is grappling with a surprising probl...

Oct 28, 2023

While much of the health care workforce is battling staff shortages, the emergen...

Opinion: The pink ribbon of breast cancer awareness needs a splash of blue for men

Opinion: The pink ribbon of breast cancer awareness nee...

Oct 28, 2023

Men get breast cancer, too. The iconic pink ribbon needs a dash of blue to refle...

STAT+: ITC recommends partial import ban of Apple Watches in Masimo patent case

STAT+: ITC recommends partial import ban of Apple Watch...

Oct 28, 2023

Over the past three years, Masimo has been engaged in a bitter legal battle with...

ISN-001 by Anterogen for Burns: Likelihood of Approval

Oct 27, 2023

ISN-001 is under clinical development by Anterogen and currently in Phase II for...

Selinexor by Karyopharm Therapeutics for Wilms’ Tumor (...

Oct 27, 2023

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

Itacitinib adipate by Incyte for Cytokine Release Syndr...

Oct 27, 2023

Itacitinib adipate is under clinical development by Incyte and currently in Phas...

Selinexor by Karyopharm Therapeutics for Atypical Terat...

Oct 27, 2023

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

Denifanstat by Sagimet Biosciences for Breast Cancer: L...

Oct 27, 2023

Denifanstat is under clinical development by Sagimet Biosciences and currently i...

Sotigalimab by Pyxis Oncology for Anaplastic Astrocytom...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Astrocytoma: Likeliho...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Glioblastoma Multifor...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Glioma: Likelihood of...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Esophageal Cancer: Li...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

STAT+: Europe takes steps to head off drug shortages, even as U.S. proposals stall

STAT+: Europe takes steps to head off drug shortages, e...

Oct 26, 2023

To address chronic drug shortages, the European Medicines Agency issued a new pl...

STAT+: Novartis claims Takeda is stonewalling efforts to review trade secrets taken by a former employee

STAT+: Novartis claims Takeda is stonewalling efforts t...

Oct 26, 2023

Novartis has gone to court to gain access to Takeda Pharmaceutical documents ove...